0001562180-19-005622.txt : 20191121 0001562180-19-005622.hdr.sgml : 20191121 20191121063131 ACCESSION NUMBER: 0001562180-19-005622 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191120 FILED AS OF DATE: 20191121 DATE AS OF CHANGE: 20191121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ADAMS ADRIAN CENTRAL INDEX KEY: 0001248144 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36352 FILM NUMBER: 191235672 MAIL ADDRESS: STREET 1: C/O AUXILIUM PHARMACEUTICALS, INC. STREET 2: 640 LEE ROAD CITY: CHESTERBROOK STATE: PA ZIP: 19355 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Akebia Therapeutics, Inc. CENTRAL INDEX KEY: 0001517022 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208756903 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 245 FIRST STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-871-2098 MAIL ADDRESS: STREET 1: 245 FIRST STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2019-11-20 false 0001517022 Akebia Therapeutics, Inc. AKBA 0001248144 ADAMS ADRIAN C/O AKEBIA THERAPEUTICS, INC. 245 FIRST ST. CAMBRIDGE MA 02142 true false false false Common Stock 2019-11-20 4 P false 50000.00 3.41 A 63700.00 D The purchase reported in this Form 4 was made on the open market. The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.37 to $3.44, inclusive. The reporting person undertakes to provide Issuer, any security holder of Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote. /s/ Nicole R. Hadas, attorney-in-fact for Adrian Adams 2019-11-21